149506-79-6 Usage
Description
4-(dibenzylamino)cyclohexanone is a chemical compound with a molecular weight of 359.484 g/mol and is identified by its CAS number 2973-78-8. It is structurally characterized by an amine group attached to a cyclohexanone ring, which is further substituted by benzyl groups. 4-(dibenzylamino)cyclohexanone belongs to the class of compounds known as Benzene and substituted derivatives.
Uses
As of now, there isn't much information available regarding the specific applications of 4-(dibenzylamino)cyclohexanone. However, given its structural features, it may potentially be used in various industries such as pharmaceuticals, materials science, or chemical research. The following are hypothetical uses based on its chemical structure:
Used in Pharmaceutical Industry:
4-(dibenzylamino)cyclohexanone could be used as an intermediate compound for the synthesis of pharmaceutical drugs, given its amine and cyclohexanone functional groups, which are common in many drug molecules.
Used in Materials Science:
4-(dibenzylamino)cyclohexanone might be employed as a building block for the development of new materials with specific properties, such as improved thermal stability or enhanced solubility in certain solvents.
Used in Chemical Research:
4-(dibenzylamino)cyclohexanone could be utilized in academic or industrial research settings to study its physical and chemical properties, such as melting point, boiling point, solubility, and stability, as well as its potential reactivity with other compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 149506-79-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,5,0 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 149506-79:
(8*1)+(7*4)+(6*9)+(5*5)+(4*0)+(3*6)+(2*7)+(1*9)=156
156 % 10 = 6
So 149506-79-6 is a valid CAS Registry Number.
149506-79-6Relevant articles and documents
NOVEL DUAL MODE OF ACTION SOLUBLE GUANYLATE CYCLASE ACTIVATORS AND PHOSPHODIESTERASE INHIBITORS AND USES THEREOF
-
, (2021/12/28)
The present invention relates to compounds of formula (I), or pharmaceutically acceptable salt, solvate or hydrate thereof, wherein said compound of formula (I) comprises at least one covalently bound -ONO2 or -ONO moiety and at most four covalently bound -ONO2 or -ONO moieties, and wherein AR, R1, X, R3 and R4 are as defined in claim 1; and pharmaceutical compositions thereof, and their use in methods of treating or preventing a disease alleviated by inhibition of PDE5 in a human or in a non-human mammal.
Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β
Ortega, Jose Antonio,Arencibia, Jose M.,Minniti, Elirosa,Byl, Jo Ann W.,Franco-Ulloa, Sebastian,Borgogno, Marco,Genna, Vito,Summa, Maria,Bertozzi, Sine Mandrup,Bertorelli, Rosalia,Armirotti, Andrea,Minarini, Anna,Sissi, Claudia,Osheroff, Neil,De Vivo, Marco
, p. 12873 - 12886 (2020/11/17)
We disclose a novel class of 6-Amino-Tetrahydroquinazoline derivatives that inhibit human topoisomerase II (topoII), a validated target of anticancer drugs. In contrast to topoII-Targeted drugs currently in clinical use, these compounds do not act as topo
HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ABNORMAL CELLULAR PROLIFERATION
-
Page/Page column 163, (2019/07/20)
This invention is in the area of heterocyclic-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.
